Abstract
Since its detection in 2015 in Brazil, Zika virus (ZIKV) has remained in the spotlight of international public health and research as an emerging arboviral pathogen. In addition to single infection, ZIKV may occur in co-infection with dengue (DENV) and chikungunya (CHIKV) viruses, with whom ZIKV shares geographic distribution and the mosquito Aedes aegypti as a vector. The main mosquito immune response against arboviruses is RNA interference (RNAi). It is unknown whether or not the dynamics of the RNAi response differ between single arboviral infections and co-infections. In this study, we investigated the interaction of ZIKV and DENV, as well as ZIKV and CHIKV co-infections with the RNAi response in Ae. aegypti. Using small RNA sequencing, we found that the efficiency of small RNA production against ZIKV -a hallmark of antiviral RNAi—was mostly similar when comparing single and co-infections with either DENV or CHIKV. Silencing of key antiviral RNAi proteins, showed no change in effect on ZIKV replication when the cell is co-infected with ZIKV and DENV or CHIKV. Interestingly, we observed a negative effect on ZIKV replication during CHIKV co-infection in the context of Ago2-knockout cells, though his effect was absent during DENV co-infection. Overall, this study provides evidence that ZIKV single or co-infections with CHIKV or DENV are equally controlled by RNAi responses. Thus, Ae. aegypti mosquitoes and derived cells support co-infections of ZIKV with either CHIKV or DENV to a similar level than single infections, as long as the RNAi response is functional.
Funder
Deutsches Zentrum für Infektionsforschung
Horizon 2020 Framework Programme
UK MRC
Horizon 2020
DFG Research Infrastructure NGS_CC
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference51 articles.
1. The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations.;IS Filgueiras;PLoS neglected tropical diseases.,2021
2. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development.;P Pielnaa;Virology.,2020
3. Epidemic arboviral diseases: priorities for research and public health;A Wilder-Smith;The Lancet Infectious diseases,2017
4. Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus;JJ Waggoner;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.,2016
5. Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014;O Dupont-Rouzeyrol M;Emerging infectious diseases,2015